litlas
Log inCreate account

David M. Margolis

Active 1978–2025

160
Papers
24,611
Citations
86
h-index
148
i10-index

Citations

Citations per year for David M. Margolis1980: 1 citations1983: 1 citations1986: 1 citations1988: 1 citations1991: 2 citations1992: 3 citations1993: 2 citations1994: 7 citations1995: 8 citations1996: 9 citations1997: 8 citations1998: 15 citations1999: 16 citations2000: 38 citations2001: 28 citations2002: 30 citations2003: 28 citations2004: 38 citations2005: 34 citations2006: 49 citations2007: 49 citations2008: 65 citations2009: 117 citations2010: 130 citations2011: 206 citations2012: 212 citations2013: 239 citations2014: 256 citations2015: 266 citations2016: 216 citations2017: 193 citations2018: 174 citations2019: 713 citations2020: 1,226 citations2021: 1,512 citations2022: 950 citations2023: 601 citations2024: 896 citations2025: 364 citations2026: 6 citations1981–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown1989–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,512 citing papers, 34.9% of this breakdownChina: 682 citing papers, 6.8% of this breakdownUnited Kingdom: 609 citing papers, 6.1% of this breakdownCanada: 405 citing papers, 4% of this breakdownFrance: 405 citing papers, 4% of this breakdownGermany: 391 citing papers, 3.9% of this breakdownItaly: 311 citing papers, 3.1% of this breakdownAustralia: 288 citing papers, 2.9% of this breakdownSpain: 277 citing papers, 2.7% of this breakdownNetherlands: 249 citing papers, 2.5% of this breakdownSouth Africa: 220 citing papers, 2.2% of this breakdownSwitzerland: 214 citing papers, 2.1% of this breakdown
0%34.9%Other 24.8%

Institutions

Fields

  • Medicine51.8%
  • Immunology and Microbiology30.4%
  • Biochemistry, Genetics and Molecular Biology12.5%
  • Materials Science1%
  • Neuroscience1%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.7%

Topics

  • HIV Research and Treatment11.8%
  • SARS-CoV-2 and COVID-19 Research7.3%
  • HIV/AIDS drug development and treatment6.3%
  • HIV/AIDS Research and Interventions6.3%
  • Immune Cell Function and Interaction4.3%
  • COVID-19 Clinical Research Studies4.2%
  • Other59.8%

Coauthors

All papers

Open in search
  1. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Authors: Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle, Lara E. Coelho, Robinson Cabello, Suwat Chariyalertsak, Eileen F. Dunne, Ian Frank, Jorge A. Gallardo-Cartagena, Aditya H. Gaur, Pedro Gonzáles, Trần Việt Hà, Juan Hinojosa, Esper G. Kallás, Colleen F. Kelley, Marcelo Losso, José Valdez Madruga, Keren Middelkoop, Nittaya Phanuphak, Breno Santos, Omar Sued, Javier Valencia Huamaní, Edgar T. Overton, Shobha Swaminathan, Carlos del Rı́o, Roy M. Gulick, Paul Richardson, Philip A. Sullivan, Estelle Piwowar‐Manning, Mark A. Marzinke, Craig W. Hendrix, Maoji Li, Zhe Wang, Jeanne Marrazzo, Eric S. Daar, Aida Asmelash, Todd T. Brown, Peter L. Anderson, Susan H. Eshleman, Marcus Bryan, Cheryl Blanchette, Jonathan Lucas, Christina Psaros, Steven A. Safren, Jeremy Sugarman, Hyman Scott, Joseph J. Eron, Sheldon D. Fields, Nirupama Sista, Kailazarid Gomez-Feliciano, Andrea Jennings, Ryan Kofron, Timothy H. Holtz, Katherine Shin, James F. Rooney, Kimberly Y. Smith, William Spreen, David M. Margolis, Alex R. Rinehart, Adeola Adeyeye, Myron S. Cohen, Marybeth McCauley, Beatriz Grinsztejn - New England Journal of Medicine 2021 cited by 853

  2. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

    Authors: Yixuan J. Hou, Kenichi Okuda, Caitlin E. Edwards, David R. Martinez, Takanori Asakura, Kenneth H. Dinnon, Takafumi Kato, Rhianna E. Lee, Boyd L. Yount, Teresa Mascenik, Gang Chen, Kenneth N. Olivier, Andrew J. Ghio, Longping V. Tse, Sarah R. Leist, Lisa E. Gralinski, Alexandra Schäfer, Hong Dang, Rodney C. Gilmore, Satoko Nakano, Ling Sun, M. Leslie Fulcher, Alessandra Livraghi-Butrico, Nathan I. Nicely, Mark J. Cameron, Cheryl Cameron, David J. Kelvin, Aravinda de Silva, David M. Margolis, Alena J. Markmann, Luther A. Bartelt, Ross E. Zumwalt, Fernando J. Martínez, Steven Salvatore, Alain Borczuk, Purushothama Rao Tata, Vishwaraj Sontake, Adam J. Kimple, Ilona Jaspers, Wanda K. O’Neal, Scott H. Randell, Richard C. Boucher, Ralph S. Baric - Cell 2020 cited by 1,676

  3. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Authors: Yixuan J. Hou, S. Chiba, Peter Halfmann, Camille Ehré, Makoto Kuroda, Kenneth H. Dinnon, Sarah R. Leist, Alexandra Schäfer, Noriko Nakajima, Kenta Takahashi, Rhianna E. Lee, Teresa Mascenik, Rachel L. Graham, Caitlin E. Edwards, Longping V. Tse, Kenichi Okuda, Alena J. Markmann, Luther A. Bartelt, Aravinda de Silva, David M. Margolis, Richard C. Boucher, Scott H. Randell, Tadaki Suzuki, Lisa E. Gralinski, Yoshihiro Kawaoka, Ralph S. Baric - Science 2020 cited by 1,003

  4. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy

    Authors: Yuyang Tang, Antoine Chaillon, Sara Gianella, Lilly Wong, Dajiang Li, Theresa L. Simermeyer, Magali Porrachia, Caroline Ignacio, Brendon Woodworth, Daniel Zhong, Jiayi Du, Eduardo de la Parra Polina, Jennifer Kirchherr, Brigitte Allard, Matthew L. Clohosey, Matt Moeser, Amy Sondgeroth, Gregory D. Whitehill, Vidisha Singh, Amir Dashti, Davey M. Smith, Joseph J. Eron, Katherine J. Bar, Ann Chahroudi, Sarah Joseph, Nancie M. Archin, David M. Margolis, Guochun Jiang - Journal of Clinical Investigation 2023 cited by 146

  5. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

    Authors: Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey, Alyssa D. Brooks, Rae Ann Spagnuolo, David M. Irlbeck, Cameron Mattingly, Phong T. Ho, Nils Schoof, Corinne G. Cammon, Greg K. Tharp, Matthew Kanke, Zhang Wang, Rachel A. Cleary, Amit A. Upadhyay, Chandrav De, Saintedym R. Wills, Shane D. Falcinelli, Cristin M. Galardi, Hasse Walum, Nathaniel J. Schramm, Jennifer Deutsch, Jeffrey D. Lifson, Christine M. Fennessey, Brandon F. Keele, Sherrie Jean, Sean Maguire, Baolin Liao, Edward P. Browne, Robert G. Ferris, Jessica H. Brehm, David Favre, Thomas H. Vanderford, Steven E. Bosinger, Corbin D. Jones, Jean‐Pierre Routy, Nancie M. Archin, David M. Margolis, Angela Wahl, Richard M. Dunham, Guido Silvestri, Ann Chahroudi, J. Víctor García - Nature 2020 cited by 319

  6. The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

    Authors: Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut, Alena J. Markmann, Caleb Cornaby, Luther A. Bartelt, Susan R. Weiss, Yara Park, Caitlin E. Edwards, Eric T. Weimer, Erin M. Scherer, Nadine Rouphael, Srilatha Edupuganti, Daniela Weiskopf, Longping V. Tse, Yixuan J. Hou, David M. Margolis, Alessandro Sette, Matthew H. Collins, John L. Schmitz, Ralph S. Baric, Aravinda M. de Silva - Science Immunology 2020 cited by 984

  7. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Authors: Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Radwa Sharaf, Wendy Hartogensis, Jeffrey M. Jacobson, Elizabeth Connick, Paul A. Volberding, Daniel J. Skiest, David M. Margolis, Michael C. Sneller, Susan J. Little, Sara Gianella, Davey M. Smith, Daniel R. Kuritzkes, Roy M. Gulick, John W. Mellors, Vikram Mehraj, Rajesh T. Gandhi, Ronald T. Mitsuyasu, Robert T. Schooley, Keith Henry, Pablo Tebas, Steven G. Deeks, Tae‐Wook Chun, Ann C. Collier, Jean‐Pierre Routy, Frederick Hecht, Bruce D. Walker, Jonathan Z. Li - The Journal of Infectious Diseases 2018 cited by 205

  8. Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

    Authors: Amanda M. Crooks, Rosalie Bateson, Anna B. Cope, Noelle Dahl, Morgan K. Griggs, JoAnn D. Kuruc, Cynthia L. Gay, Joseph J. Eron, David M. Margolis, Ronald J. Bosch, Nancie M. Archin - The Journal of Infectious Diseases 2015 cited by 425

  9. Discovery of a large-scale, cell-state-responsive allosteric switch in the 7SK RNA using DANCE-MaP

    Authors: Samuel W. Olson, Anne‐Marie W. Turner, J. Winston Arney, Irfana Saleem, Chase A. Weidmann, David M. Margolis, Kevin M. Weeks, Anthony M. Mustoe - Molecular Cell 2022 cited by 115

  10. HIV latency is reversed by ACSS2-driven histone crotonylation

    Authors: Guochun Jiang, Don X. Nguyen, Nancie M. Archin, Steven A. Yukl, Gema Méndez‐Lagares, Yuyang Tang, Maher Elsheikh, George R. Thompson, Dennis J. Hartigan-O’Connor, David M. Margolis, Joseph K. Wong, Satya Dandekar - Journal of Clinical Investigation 2018 cited by 172

  11. Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

    Authors: Julia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, S. Abigail Smith, Erick White, Gregory K. Tharp, Hasse Walum, Kathleen Busman‐Sahay, Christian R. Aguilera-Sandoval, William O. Thayer, Rae Ann Spagnuolo, Martina Kovářová, Angela Wahl, Barbara Cervasi, David M. Margolis, Thomas H. Vanderford, Diane G. Carnathan, Mirko Paiardini, Jeffrey D. Lifson, John H. Lee, Jeffrey T. Safrit, Steven E. Bosinger, Jacob D. Estes, Cynthia A. Derdeyn, J. Víctor García, Deanna A. Kulpa, Ann Chahroudi, Guido Silvestri - Nature 2020 cited by 195

  12. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

    Authors: Raphael J. Landovitz, Sue Li, Joseph J. Eron, Beatriz Grinsztejn, Halima Dawood, Albert Liu, Manya Magnus, Mina C. Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A. Marzinke, Susan H. Eshleman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R. Rinehart, David M. Margolis, Myron S. Cohen, Marybeth McCauley, Craig W. Hendrix - The Lancet HIV 2020 cited by 171

  13. Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

    Authors: Andrew Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar Gill, David L. Porter, Daria V. Babushok, Ivan Maillard, Martin Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei‐Ting Hwang, David M. Margolis, Keith W. Pratz - Blood Advances 2022 cited by 100

  14. Curing HIV: Seeking to Target and Clear Persistent Infection

    Authors: David M. Margolis, Nancie M. Archin, Myron S. Cohen, Joseph J. Eron, Guido Ferrari, J. Víctor García, Cynthia L. Gay, Nilu Goonetilleke, Sarah Joseph, Ronald Swanstrom, Anne‐Marie W. Turner, Angela Wahl - Cell 2020 cited by 188

  15. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

    Authors: Deanna Kerrigan, Andrea Mantsios, Miguel Górgolas, Marisa Montes, Federico Pulido, Cynthia Brinson, Jerome Devente, Gary Richmond, S. Wilson Beckham, Paige Hammond, David M. Margolis, Miranda Murray - PLoS ONE 2018 cited by 175

  16. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

    Authors: François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink, W. D. Hardy, Carlo Torti, Chloe Orkin, Mark Bloch, Daniel Podzamczer, Vadim Pokrovsky, Federico Pulido, Steve Almond, David M. Margolis, Clare Brennan, Sherene Min - The Lancet 2013 cited by 546

  17. Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader

    Authors: Frances Potjewyd, Anne‐Marie W. Turner, Joshua Beri, Justin M. Rectenwald, Jacqueline L. Norris‐Drouin, Stephanie H. Cholensky, David M. Margolis, Kenneth H. Pearce, Laura E. Herring, Lindsey I. James - Cell chemical biology 2019 cited by 177

  18. HIV reservoirs: what, where and how to target them

    Authors: Melissa J. Churchill, Steven G. Deeks, David M. Margolis, Robert F. Siliciano, Ronald Swanstrom - Nature Reviews Microbiology 2015 cited by 308

  19. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication

    Authors: Haitao Guo, Qi Wang, Khader Ghneim, Li Wang, Elena Rampanelli, Elizabeth Holley-Guthrie, Liang Cheng, Carolina Garrido, David M. Margolis, Leigh Anne Eller, Merlin L. Robb, Rafick‐Pierre Sékaly, Xian Chen, Lishan Su, Jenny P.‐Y. Ting - Nature Immunology 2021 cited by 111

  20. Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

    Authors: Julia H. Friedman, Won‐Kyung Cho, Chung K. Chu, Kara S. Keedy, Nancie M. Archin, David M. Margolis, Jonathan Karn - Journal of Virology 2011 cited by 285

  21. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption

    Authors: Justin Harper, Shari N. Gordon, Chi Ngai Chan, Hong Wang, Emily Lindemuth, Cristin M. Galardi, Shane D. Falcinelli, Samuel L M Raines, Jenna Read, Kevin Nguyen, Colleen S. McGary, Michael Nekorchuk, Kathleen Busman‐Sahay, James Schawalder, Colin T. King, María Pino, Luca Micci, Barbara Cervasi, Sherrie Jean, Andrew Sanderson, Brian A. Johns, A. Alicia Koblansky, Heather Amrine‐Madsen, Jeffrey D. Lifson, David M. Margolis, Guido Silvestri, Katharine J. Bar, David Favre, Jacob D. Estes, Mirko Paiardini - Nature Medicine 2020 cited by 106

  22. HIV post-treatment controllers have distinct immunological and virological features

    Authors: Behzad Etemad, Xiaoming Sun, Yijia Li, Meghan Melberg, Daniela Moïsi, Rachel Gottlieb, Hayat Ahmed, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Yuko Yuki, Maureen P. Martin, Mary Carrington, Rajesh T. Gandhi, Jeffrey M. Jacobson, Paul A. Volberding, Elizabeth Connick, Ronald T. Mitsuyasu, Ian Frank, Michael S. Saag, Joseph J. Eron, Daniel J. Skiest, David M. Margolis, Diane V. Havlir, Robert T. Schooley, Michael M. Lederman, Xu G. Yu, Jonathan Z. Li - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 65

  23. The Challenge of Finding a Cure for HIV Infection

    Authors: Douglas D. Richman, David M. Margolis, Martin Delaney, Warner C. Greene, Daria J. Hazuda, Roger J. Pomerantz - Science 2009 cited by 851

  24. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

    Authors: Shalini Shenoy, Mary Eapen, Julie A. Panepinto, Brent R. Logan, Juan Wu, Allistair Abraham, Joel A. Brochstein, Sonali Chaudhury, Kamar Godder, Ann E. Haight, Kimberly A. Kasow, Kathryn Leung, Martin Andreánsky, Monica Bhatia, Jignesh Dalal, Hilary Haines, Jennifer Jaroscak, Hillard M. Lazarus, John E. Levine, Lakshmanan Krishnamurti, David M. Margolis, Gail Megason, Lolie C. Yu, Michael A. Pulsipher, Iris D. Gersten, Nancy DiFronzo, Mary M. Horowitz, Mark C. Walters, Naynesh Kamani - Blood 2016 cited by 211